The T cell architecture of pancreatic ductal adenocarcinoma

The T cell architecture of pancreatic ductal adenocarcinoma

Show other versions (1)

Bibliografske podrobnosti
Main Authors:	Sivakumar, S, Abu-Shah, E, Ahern, D, Mangal, N, Reddy, S, Rendek, A, Silva, M, Soonawalla, Z, Middleton, M, Dustin, M
Format:	Conference item
Jezik:	English
Izdano:	Elsevier 2019

Podobne knjige/članki

The T-cell architecture of pancreatic ductal adenocarcinoma
od: Sivakumar, S, et al.
Izdano: (2019)

Activated regulatory T-cells, dysfunctional and senescent T-cells hinder the immunity in pancreatic cancer
od: Sivakumar, S, et al.
Izdano: (2021)

Immuno-phenotypes of Pancreatic Ductal Adenocarcinoma: Metaanalysis of transcriptional subtypes
od: De Santiago, I, et al.
Izdano: (2018)

Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
od: De Santiago, I, et al.
Izdano: (2019)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
od: Wang, L, et al.
Izdano: (2015)

Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?
od: Henry Smith, et al.
Izdano: (2024-05-01)

Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells
od: Ashwin Jainarayanan, et al.
Izdano: (2023-04-01)

Manipulating regulatory T cells: is it the key to unlocking effective immunotherapy for pancreatic ductal adenocarcinoma?
od: Smith, H, et al.
Izdano: (2024)

Pseudotime dynamics in pancreatic ductal adenocarcinoma reveal different mechanisms of hindrance in immunity through bifurcation of regulatory and cytotoxic T-cell differentiation
od: Jainarayanan, AK, et al.
Izdano: (2021)

Stromal architecture directs early dissemination in pancreatic ductal adenocarcinoma
od: Arja Ray, et al.
Izdano: (2022-02-01)

Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma.
od: Ole Helm, et al.
Izdano: (2014-01-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
od: Apeksha Kakkar, et al.
Izdano: (2016-12-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
od: Nausika Betriu, et al.
Izdano: (2021-02-01)

Apoptotic pathways in pancreatic ductal adenocarcinoma
od: Saur Dieter, et al.
Izdano: (2008-07-01)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
od: Anton Deicher, et al.
Izdano: (2018-06-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
od: Raffaele Pezzilli, et al.
Izdano: (2011-07-01)

Role of Endoscopic Ultrasound in Diagnosis of Pancreatic Ductal Adenocarcinoma
od: Abhirup Chatterjee, et al.
Izdano: (2023-12-01)

MORPHOLOGICAL AND EXPRESSION FEATURES OF DUCTAL PANCREATIC ADENOCARCINOMA
od: Yu. Yu. Rakina, et al.
Izdano: (2017-09-01)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
od: Lau, Allison N, et al.
Izdano: (2021)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
od: Allison N Lau, et al.
Izdano: (2020-07-01)

Ubiquitin signaling in pancreatic ductal adenocarcinoma
od: Shengnan Lv, et al.
Izdano: (2023-12-01)

Molecular imaging of pancreatic ductal adenocarcinoma
od: Wei Huang, et al.
Izdano: (2023-10-01)

Oral mycobiota and pancreatic ductal adenocarcinoma
od: Ailin Wei, et al.
Izdano: (2022-12-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
od: Jin-Tao Li, et al.
Izdano: (2019-11-01)

Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
od: Sofia Parrasia, et al.
Izdano: (2021-01-01)

Cellular crosstalk of regulatory T cells in pancreatic ductal adenocarcinoma
od: Xuqing Shi, et al.
Izdano: (2024-06-01)

Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
od: Rita Rebelo, et al.
Izdano: (2021-03-01)

Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
od: Zoe C. Schmiechen, et al.
Izdano: (2021-01-01)

Pancreatic Ductal Adenocarcinoma Cortical Mechanics and Clinical Implications
od: Shantel Angstadt, et al.
Izdano: (2022-01-01)

Distinct immune cell infiltration patterns in pancreatic ductal adenocarcinoma (PDAC) exhibit divergent immune cell selection and immunosuppressive mechanisms
od: Sivakumar, S, et al.
Izdano: (2025)

PKM2 is not required for pancreatic ductal adenocarcinoma
od: Danai, Laura V, et al.
Izdano: (2018)

PKM2 is not required for pancreatic ductal adenocarcinoma
od: Alissandra L Hillis, et al.
Izdano: (2018-10-01)

Potential biomarkers uncovered by bioinformatics analysis in sotorasib resistant-pancreatic ductal adenocarcinoma
od: Prasanna Srinivasan Ramalingam, et al.
Izdano: (2023-06-01)

Resistance signatures to oncolytic vesiculoviruses in pancreatic ductal adenocarcinoma
od: Chelsae R. Watters, et al.
Izdano: (2025-03-01)

Molecular drivers and cells of origin in pancreatic ductal adenocarcinoma and pancreatic neuroendocrine carcinoma
od: He-Li Gao, et al.
Izdano: (2020-10-01)

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
od: Diana, A, et al.
Izdano: (2016)

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
od: Diana, A, et al.
Izdano: (2016)

Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma
od: Han Liu, et al.
Izdano: (2017-05-01)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
od: Yang Wu, et al.
Izdano: (2021-01-01)

Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
od: Wayne Croft, et al.
Izdano: (2023-06-01)